Shots:

• Bayer to transfer its small molecule research unit to Nuvisan for establishing a new research center in Berlin. The transaction is expected to close mid of 2020
• The collaboration will strengthen the healthcare cluster in Berlin- accelerating the drug development process and supports Bayer to focus on the flexibility and productivity of its R&D operating model
• The new research center will be a full-fledged research unit and will provide ~400 jobs in Berlin. Bayer retain its research activities in Berlin- which remains the HQ of its global research sites

Click here ­to­ read full press release/ article | Ref: Bayer | Image: Radar